This week on BioTech Nation, Andrew Farnum and Sarah LeBaron von Baeyer discuss Variant Bio’s unique approach to collecting genetic data - working specifically with indigenous tribes and more isolated populations around the globe. Could compiling this diverse genetic data reveal something about how to develop better drugs and diagnostics? And how might those sharing their data be ethically compensated for it?

Dr. Marc Salzberg, CEO & Chief Medical Officer of Airway Therapeutics, talks about what they are doing to help preterm babies. It may all boil down to delivering these babies a single protein as soon as they are born. 

On this week's episode of BioTech Nation, Dr. Daniel Kraft discusses the "now-near-next" approach he uses when talking about innovation in healthcare...and beyond. From biotech breakthroughs to AI "agentification", this framework can help us see the bigger picture, and envision the possibilities of where we could be headed next. 

This week on BioTech Nation, we celebrate the life of the late Dr. Phil Low, Purdue University Distinguished Professor of Chemistry and biotech entrepreneur. In this 2017 interview, he describes the development of fluorescence-guided surgery - and why it's a game-changer for cancer treatment. 

On this week's BioTech Nation...want to go to space? Well...it's never too late to follow your dreams, and Tech Nation Health Chief Correspondent Dr. Daniel Kraft joins us to talk about who could medically qualify to climb aboard and rocket into orbit. His answers may surprise you...

On this week's BioTech Nation...what could the future of American Healthcare look like? Moira speaks with Dr. Marschall Runge, University of Michigan Medical School Professor, about how Big Tech is quickly redefining the entire healthcare system. His book is, “The Great Healthcare Disruption: Big Tech, Bold Policy, and the Future of American Medicine.” 

On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial participants have seen increased function as much as 10 years post-trauma. 

On this week’s Biotech Nation, Moira speaks with Dr. Arun Swaminathan about an intervention for ALS that Coya Therapeutics is taking into phase two clinical trials. The goal? To stop progression of the disease in its tracks. It could even help in patients with Parkinson’s, Alzheimers, and Frontotemporal Dementia.

What if you could routinely screen for early cancer, detecting it while it's easier to treat? Tech Nation Health Chief Correspondent, Dr. Daniel Kraft discusses the latest diagnostics that could allow us to do just that. From blood tests to full-body scans, the future of cancer screening could mean finding cancer before obvious symptoms even begin...

On this week’s Biotech Nation, how doctors and hospitals are using AI, and how it could change the practice of medicine. Moira speaks with Dr. Robert Wachter about his book, “A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future”.